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Identity 
Other names: CDHH; T-cadherin 





A cluster of 8 cadherin genes is located on 16q22-24. 
DNA/RNA 
Note 
Promoter region of CDH13 is CpG rich and often 
hypermethylated in various malignant tumors, i.e. 
breast, lung, colorectal, skin, ovary, chronic myeloid 
leukemia, and more. 
Transcription 
3828 bp mRNA; 2145 bp open reading frame. 
Pseudogene 
Not yet reported. 
Protein 
Description 
713 amino acids. 
Unlike classical cadherin molecules, CDH13 lacks a 
transmembrane domain or cytoplasmic region, and is 
anchored to surface membrane via 
glycosylphosphatidylinositol anchor. The extracellular 
domain of CDH13 shows significant homology with 
other cadherins; however, CDH13 EC1 lacks many 
amino acids crucial for the adhesive functions. 
 
 
DNA of CDH13 gene composed of 14 coding exons. 
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Schematic representation of CDH13 protein. SP: signal peptide sequence, EC: extracellular cadherin repeat, GPI: 
glycosylphosphatidylinositol anchor. 
 
CDH13 lacks intracellular domain, which is believed to 
be critical for homophilic adhesion of other classical 
cadherins. 
Expression 
Heart, skeletal muscle, brain, bone (osteoblast), 
epidermal basal cell, endothelial cell (tumor vessel, 
active remodeling vascule). 
Controversial experiments and arguments exist for the 
expression in the liver, hepatocyte. 
Localisation 
Cell surface membrane, lipid raft (cytoplasmic and 
nuclear localization are also reported). 
Function 
CDH13 is believed to have diverse functions. 
1. Adiponectin receptor. CDH13 binds to the 
hexameric and larger adiponectin, an insulin-sensitizing 
hormone, which is secreted by adipocytes. 
2. Homophilic adhesion. Unlike other classical 
cadherins, which have the strong homophilic adhesion 
function, EC1 domain of CDH13 lacks many amino 
acids crucial for the adhesive functions. Instead CDH13 
is thought to form dimers through the non-swapped 
interface near the EC1-EC2 calcium binding site. 
3. Tumor suppressor function. Especially against 
cancer invasion; however, the exact molecular 
mechanism which is responsible for inhibiting cancer 
progression still remains unclear. 
4. Angiogenesis. CDH13 facilitates tumor 
neovascularization. In tumor microenvironment, 
CDH13 may recruit adiponectin to sequester various 
growth factors to assist the tumor associated 
angiogenesis. 
Homology 
CDH1 (approximately 38%). 
Mutations 
Note 
Silencing of CDH13 expression is often found in 
various malignant tumors. Hypermethylation of the 
promoter region is the major molecular mechanism for 
loss of CDH13 expression.  




Various malignant tumors, i.e. breast, 
lung, colorectal, skin, ovary and chronic 
myeloid leukemia 
Note 
Expression of CDH13 is downregulated by the aberrant 
methylation of the promoter region of CDH13 gene. On 
the other hand, CDH13 is over-expressed in tumor 
vascular endothelial cells and thought to support the 
neoangiogenesis. 
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